FindTrial
Sign In

Ranibizumab (Lucentis)

DRUG11 trials

Sponsors

University of Miami, Rocky Mountain Retina Consultants, The National Retina Institute, Greater Houston Retina Research, David M. Brown, M.D.

Conditions

Age-Related Macular DegenerationCentral Retinal Vein OcclusionChoroidal NeovascularizationDepressionDiabetic Macular EdemaDiabetic RetinopathyExudative Macular DegenerationFailing Bleb Following Trabeculectomy

Phase 1

Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration
CompletedNCT00395707
The National Retina InstituteMacular Degeneration
Start: 2005-08-31End: 2008-04-30Target: 20Updated: 2009-02-09
Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion
CompletedNCT00406471
Greater Houston Retina ResearchIschemic Central Retinal Vein Occlusion
Start: 2005-05-31End: 2011-01-31Updated: 2013-03-14
Photodynamic and Pharmacologic Treatment of CNV
CompletedNCT00570193
Mid-Atlantic Retina Consultations, Inc.Choroidal Neovascularization, Macular Degeneration
Start: 2006-12-31End: 2011-06-30Updated: 2012-07-10
Treatment of Failing Blebs With Ranibizumab
CompletedNCT00570726
The New York Eye & Ear InfirmaryFailing Bleb Following Trabeculectomy, Glaucoma, Open-Angle
Start: 2000-06-30End: 2007-11-30Target: 6Updated: 2014-10-15
Lucentis for New Onset Neovascular Glaucoma
WithdrawnNCT00727038
University of Illinois at ChicagoGlaucoma, Neovascular Glaucoma, New Onset Glaucoma +1
Start: 2008-01-04End: 2009-05-15Updated: 2020-02-17
Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion
NCT01011374
Retina Associates of Cleveland, IncCentral Retinal Vein Occlusion, Depression, Retinal Vein Occlusion +1
Start: 2009-11-30End: 2013-11-30Target: 45Updated: 2011-03-18
Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion
CompletedNCT01028248
California Retina ConsultantsCentral Retinal Vein Occlusion
Start: 2010-01-31End: 2013-06-30Updated: 2013-12-12
Pilot Study of X-82 in Patients With Wet AMD
CompletedNCT01674569
TyrogenexExudative Macular Degeneration
Start: 2012-10-31End: 2015-02-28Updated: 2018-08-07

Phase 2

An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD
CompletedNCT00373659
University of MiamiNeovascular Age-related Macular Degeneration
Start: 2004-08-31End: 2007-06-30Updated: 2012-06-13
Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
CompletedNCT00387582
Rocky Mountain Retina ConsultantsDiabetic Macular Edema, Diabetic Retinopathy
Start: 2006-07-31End: 2009-02-28Updated: 2014-05-06

Phase 4

Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration
TerminatedNCT00423189
David M. Brown, M.D.Age-Related Macular Degeneration
Start: 2007-01-31End: 2009-01-31Updated: 2016-03-04